Lupin LimitedNSE: LUPIN

Press Release May 31 2023

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Lupin Receives Approval from U.S. FDA for Obeticholic Acid Tablets.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases